Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
may have administered the diluent only; may have administered the diluent only; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 2-month-old male patient who received Hib (Hiberix) for prophylaxis. On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: may have administered the diluent only) and inappropriate dose of vaccine administered (Verbatim: may have administered the diluent only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 09-JAN-2025 Pharmacist stated that she was contacted by a clinic staff member who was concerned that they may have administered the diluent only portion of Hiberix to a patient within the past 1-2 months. The staff was not sure if this happened and did not know which patient it was, but they narrowed down to 5 patients, of which one of them could have received diluent only. It was possible that the 5 patients may all be given another dose, but at the time of reporting this decision was not made. The reporter did not have the lot number of the product at the time of reporting. The patient received only diluent of Hiberix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is 1 of the 5 linked cases reported by the same reporter.; Sender's Comments: US-GSK-US2025002641:Same reporter/Different patient US-GSK-US2025002645:Same reporter/Different Patient US-GSK-US2025002639:Same reporter/Different Patient US-GSK-US2025002647:Same reporter/Different patient